Effect of Anti-CD40L Antibody on Gene Expression in Mouse Eyes
Author Information
Author(s): Millar J. Cameron, Pang Iok-Hou, Wang Wan-Heng, Wang Yu, Clark Abbot F.
Primary Institution: Alcon Research, Ltd.
Hypothesis
Can anti-CD40L antibody treatment prolong adenoviral-mediated transgene expression in the mouse eye?
Conclusion
Anti-CD40L antibody treatment significantly increased both the intensity and duration of GFP expression in the mouse eye after adenoviral injection.
Supporting Evidence
- GFP expression was significantly higher in the anti-CD40L than the no antibody group.
- IVT injection produced more pronounced GFP expression than IC injection.
- Higher viral titer resulted in significantly higher GFP expression.
- Anti-CD40L antibody treatment prolonged GFP expression duration to over six weeks.
Takeaway
This study shows that a special treatment can help a gene introduced into mouse eyes last longer and work better.
Methodology
Mice were injected with an adenoviral vector encoding GFP, with or without anti-CD40L antibody treatment, and GFP expression was assessed by fluorescence intensity and histological analysis.
Potential Biases
Potential bias in fluorescence grading due to subjective assessment by masked researchers.
Limitations
The study primarily focused on short-term effects and did not explore long-term safety or efficacy in a broader context.
Participant Demographics
Adult male Balb/cJ mice, weighing between 20 and 30 g.
Statistical Information
P-Value
p=0.013
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website